Worth reading
67In focus
Scored from 5 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
235
¥100 million (year-on-year increase in core operating profit)Wording
Avoiding a definitive answer
How definitive the wording is.Contents of this document
Earnings presentationFirst quarter of fiscal 20267 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥4,600 million+11.0%
Operating profit¥484 million+280.0%
Net income¥321 million
Results for the three months of the current quarter
Revenue
¥4,600 million
Core operating profit
¥501 million
Operating profit
¥484 million
Profit before quarterly income taxes
¥477 million
Quarterly profit attributable to owners of the parent
¥321 million
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
- Volume variance¥3 million
- Terms of trade¥229 million
- Fixed costs and other factors¥3 million
- Impact of the situation in the Middle East-50 Approximately ¥100 million
- Impact of the situation in the Middle East on B&GM-30 Approximately ¥100 million
- Structural improvements, rationalization and other factors80 Approximately ¥100 million
- One-time inventory valuation differences and other factors180 Approximately ¥100 million
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
- ¥160 /US$AssumptionsExchange rate
- ¥104,500 /KLAssumptionsDomestic naphtha price
- ¥90,000 /KLAssumptionsQ2 FY2026 domestic naphtha price
New initiatives
- Acquisition of Ultradent Products, Inc. in the United States (scheduled for Q2 FY2026; acquisition expenditure of US$900 million)
- Expansion of eyeglass lens monomer capacity (Japan; announced 3 June 2026)
- Construction of a new high-performance PP facility (Japan; 200KT)
- CNT pellicle production facility for next-generation EUV lithography (Japan; 5,000 sheets)
- Production optimization through the integration of domestic polyolefin operations
Key KPIsA metric the company considers important as a management benchmark.
- Exchange rate¥159 /US$Year on year against the same period last year+14.0%
- Domestic naphtha price¥118,900 /KLYear on year against the same period last year+52,500.0%
- Core operating margin in Growth Areas11.6 %Year on year against the same period last year-0.1%
Segment results
- Life & Healthcare SolutionsRevenue¥622 millionCore operating profit¥68 million
- Mobility SolutionsRevenue¥1,425 millionCore operating profit¥148 million
- ICT SolutionsRevenue¥778 millionCore operating profit¥111 million
- Growth AreasRevenue¥2,825 millionCore operating profit¥327 millionCore operating profit_yoy_pct10
- Basic & Green MaterialsRevenue¥1,736 millionCore operating profit¥198 million
- OtherRevenue¥39 millionCore operating profit¥-24 million
Financial targets
Net debt-to-equity ratio
Actual results0.7 times
Capital expenditures
¥1,340 100 million FY2026 forecast
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | First quarter of fiscal 2026 |
| Net Sales | ¥4,600 million (YoY +11.0%) |
| Operating profit | ¥484 million (YoY +280.0%) |
| Net income | ¥321 million |
| Results for the three months of the current quarter | Revenue ¥4,600 million / Core operating profit ¥501 million / Operating profit ¥484 million / Profit before quarterly income taxes ¥477 million / Quarterly profit attributable to owners of the parent ¥321 million |
| Segment results | Segment Life & Healthcare Solutions / Revenue ¥622 million / Revenue_yoy_pct Not disclosed / Core operating profit ¥68 million / Core operating profit_yoy_pct Not disclosed, Segment Mobility Solutions / Revenue ¥1,425 million / Revenue_yoy_pct Not disclosed / Core operating profit ¥148 million / Core operating profit_yoy_pct Not disclosed, Segment ICT Solutions / Revenue ¥778 million / Revenue_yoy_pct Not disclosed / Core operating profit ¥111 million / Core operating profit_yoy_pct Not disclosed, Segment Growth Areas / Revenue ¥2,825 million / Revenue_yoy_pct Not disclosed / Core operating profit ¥327 million / Core operating profit_yoy_pct 10, Segment Basic & Green Materials / Revenue ¥1,736 million / Revenue_yoy_pct Not disclosed / Core operating profit ¥198 million / Core operating profit_yoy_pct Not disclosed, Segment Other / Revenue ¥39 million / Revenue_yoy_pct Not disclosed / Core operating profit ¥-24 million / Core operating profit_yoy_pct Not disclosed |
| Breakdown of Factors Affecting the Change | Factors Volume variance / Amount ¥3 million, Factors Terms of trade / Amount ¥229 million, Factors Fixed costs and other factors / Amount ¥3 million, Factors Impact of the situation in the Middle East / Amount -50 Approximately ¥100 million, Factors Impact of the situation in the Middle East on B&GM / Amount -30 Approximately ¥100 million, Factors Structural improvements, rationalization and other factors / Amount 80 Approximately ¥100 million, Factors One-time inventory valuation differences and other factors / Amount 180 Approximately ¥100 million |
| Key KPIs | Indicator name Exchange rate / Value ¥159 /US$ / Year on year against the same period last year ¥14 /US$, Indicator name Domestic naphtha price / Value ¥118,900 /KL / Year on year against the same period last year ¥52,500 /KL, Indicator name Core operating margin in Growth Areas / Value 11.6 % / Year on year against the same period last year -0.1 % |
| Assumptions Underlying the Business Outlook | Assumptions Exchange rate / Value ¥160 /US$, Assumptions Domestic naphtha price / Value ¥104,500 /KL, Assumptions Q2 FY2026 domestic naphtha price / Value ¥90,000 /KL |
| Financial targets | Net debt-to-equity ratio Actual results 0.7 times |
| Capital expenditures | ¥1,340 100 million (FY2026 forecast) |
| New initiatives | Acquisition of Ultradent Products, Inc. in the United States (scheduled for Q2 FY2026; acquisition expenditure of US$900 million), Expansion of eyeglass lens monomer capacity (Japan; announced 3 June 2026), Construction of a new high-performance PP facility (Japan; 200KT), CNT pellicle production facility for next-generation EUV lithography (Japan; 5,000 sheets), Production optimization through the integration of domestic polyolefin operations |
Items this document does not state (18)
Ordinary incomeGross Profit MarginOperating profit marginSelling, general and administrative expensesFull-year earnings forecastProgress against full-year forecastSelf-assessment against the planUnit price and quantity metricsNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsAnnual DividendPayout ratioAcquisition of treasury sharesOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Factors driving the increase in profit included higher sales volumes in growth areas, the benefits of structural improvements implemented in FY2025, rationalization, foreign exchange gains resulting from yen depreciation, and one-time inventory valuation gains associated with the surge in naphtha prices. These benefits were partly offset by production and sales volume reductions resulting from the situation in the Middle East, as well as deterioration in yields and energy efficiency.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.